Birgit Zech

Characterization of a Conserved Structural Determinant Controlling Protein Kinase Sensitivity to Selective Inhibitors

Stephanie Blencke, Birgit Zech, Ola Engkvist et al. · Chemistry & Biology · 2004 · 142 citations · Full text

Drug Target, Signal Transduction, Medicine +8

Proteome-wide Identification of Cellular Targets Affected by Bisindolylmaleimide-type Protein Kinase C Inhibitors

Dirk Brehmer, Klaus Godl, Birgit Zech et al. · Molecular & Cellular Proteomics · 2004 · 106 citations · Full text

Drug Target, Cdk2 Crystal Structure, Cellular Targets Affected +19

Small-molecule inhibitors binding to protein kinase. Part II: the novel pharmacophore approach of type II and type III inhibition

AC Backes, Birgit Zech, Béatrice Felber et al. · Expert Opinion on Drug Discovery · 2008 · 105 citations

Small-molecule inhibitors binding to protein kinases. Part I: exceptions from the traditional pharmacophore approach of type I inhibition

AC Backes, Birgit Zech, Béatrice Felber et al. · Expert Opinion on Drug Discovery · 2008 · 83 citations

Identification and characterization of amphiphysin II as a novel cellular interaction partner of the hepatitis C virus NS5A protein

Birgit Zech, Alexander Kurtenbach, Nicole Krieger et al. · Journal of General Virology · 2003 · 67 citations

Viral Replication, Hepatitis C Virus, Hcv Life Cycle +17